Brief: Rapt Therapeutics Q3 Net Income USD -18.432 Million
Nov 12 (Reuters) - Rapt Therapeutics Q3 operating income USD -19.788 million. * Q3 operating expenses USD 19.788 million * Q3 basic EPS USD -0.47
Nov 12 (Reuters) - Rapt Therapeutics Q3 operating income USD -19.788 million. * Q3 operating expenses USD 19.788 million * Q3 basic EPS USD -0.47